U-Chart Analysis:TOWA PHARMACEUTICAL CO.,LTD.:4553

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TOWA PHARMACEUTICAL CO.,LTD. Go to web site 4553 Medicals 東証プライム March 1, 2000 1994.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2025年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 45,471 29,650 24,257 32,830 22,915
Other Current AssetsHelp 201,835 188,068 158,733 134,034 114,375
Tangible Fixed AssetsHelp 168,423 153,642 127,004 99,873 85,898
Intangible Fixed AssetHelp 17,727 18,018 18,332 18,999 7,913
Investments and OthersHelp 9,252 8,707 8,408 7,297 -20,046
Total AssetsHelp 470,823 430,653 371,347 332,097 245,668
Total Current LiabilitiesHelp 92,321 85,636 84,139 120,734 54,971
Total Long-term LiabilitiesHelp 206,878 189,124 150,314 79,194 74,098
Shareholder's EquityHelp 171,624 155,893 136,894 132,169 116,599
Total LiabilitiesHelp 470,823 430,653 371,347 332,097 245,668

TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2025年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 259,594 227,934 208,859 165,615 154,900
Total Sales 259,594 227,934 208,859 165,615 154,900
Cost of SalesHelp 164,865 146,551 136,145 95,429 89,448
Other Costs and RevenueHelp 75,742 65,210 70,513 54,271 51,494
Total CostsHelp 240,607 211,761 206,658 149,700 140,942
Net RevenueHelp 94,729 81,383 72,714 70,186 65,452
Earnings Before TaxHelp 26,330 24,459 4,605 22,246 18,728
Net IncomeHelp 18,987 16,173 2,201 15,915 13,958
Net Income 18,987 16,173 2,201 15,915 13,958

TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2025年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 23,613 8,213 2,545 22,129 12,354
Investing Cash Flow(ICF)Help -31,287 -40,394 -30,284 -59,729 -9,100
Financing Cash FlowHelp 21,567 35,407 17,481 46,540 184
Exchange Difference of Cash and Cash EquivalentsHelp 1,916 2,167 1,685 975 761
Net Increase and Decrease in Cash and Cash Equivalentsn 15,809 5,393 -8,573 9,915 4,199

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TOWA PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

STELLA PHARMA CORPORATION
KAKEN PHARMACEUTICAL CO.,LTD.
Kidswell Bio Corporation
Daito Pharmaceutical Co.,Ltd.
PRISM BioLab
TOWA PHARMACEUTICAL CO.,LTD.
DAIICHI SANKYO COMPANY, LIMITED
CanBas Co.,Ltd.
Veritas In Silico
Nichi-Iko Pharmaceutical Co.,Ltd.